Security key
471871202
Jasper Therapeutics, Inc. - Voting Common Stock (JSPR)
CUSIP: 471871202
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Voting Common Stock
- Shares outstanding
- 27,779,583
- Total 13F shares
- 15,646,434
- Share change
- +581,667
- Total reported value
- $334,368,683
- Put/Call ratio
- 44%
- Price per share
- $21.38
- Number of holders
- 84
- Value change
- +$15,008,656
- Number of buys
- 44
- Number of sells
- 29
Report period
Q4 2024
Institutions
84
Top holders
10
JSPR full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Jasper Therapeutics, Inc. SEC filings
Jasper Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 471871202
Recent filing periods:
Top shareholders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Velan Capital Investment Management LP |
13F
3/4/5
|
Company · 10%+ Owner |
5.2%
|
1,433,828
|
$26,970,305 | — | 30 Sep 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
4.8%
|
1,343,665
|
$25,274,339 | — | 30 Sep 2024 | |
| Carlyle Group Inc. |
13F
3/4/5
|
Company · Former 10% Owner |
3.8%
|
1,066,189
|
$19,895,087 | — | 30 Sep 2024 | |
| Qiming U.S. Ventures Management, LLC |
13F
|
Company |
3.3%
|
928,964
|
$17,473,813 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
2.9%
|
800,028
|
$15,048,527 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
694,425
|
$13,062,134 | — | 30 Sep 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
2.1%
|
584,642
|
$10,997,116 | — | 30 Sep 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.1%
|
581,538
|
$10,938,730 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.1%
|
579,636
|
$9,610,365 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2%
|
565,722
|
$10,641,230 | — | 30 Sep 2024 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.8%
|
497,000
|
$9,348,570 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.8%
|
495,104
|
$9,312,906 | — | 30 Sep 2024 | |
| BRAIDWELL LP |
13F
|
Company |
1.7%
|
483,300
|
$9,090,873 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.7%
|
459,088
|
$8,635,445 | — | 30 Sep 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
1.4%
|
399,466
|
$7,513,955 | — | 30 Sep 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
1.3%
|
353,500
|
$6,649,335 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.3%
|
350,000
|
$6,583,500 | — | 30 Sep 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
1.3%
|
350,000
|
$6,583,500 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
325,881
|
$6,129,821 | — | 30 Sep 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.2%
|
322,380
|
$6,063,968 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.93%
|
257,416
|
$4,842,882 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.77%
|
214,883
|
$4,041,949 | — | 30 Sep 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.76%
|
211,526
|
$3,978,802 | — | 30 Sep 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.68%
|
189,270
|
$3,560,169 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.51%
|
141,564
|
$2,662,819 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.47%
|
131,259
|
$2,468,982 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
106,940
|
$2,011,541 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.3%
|
83,417
|
$1,569,074 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.24%
|
66,325
|
$1,247,573 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
55,765
|
$1,048,940 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.2%
|
55,175
|
$1,037,842 | — | 30 Sep 2024 | |
| Fernwood Investment Management, LLC |
13F
|
Company |
0.19%
|
52,897
|
$994,993 | — | 30 Sep 2024 | |
| Mariner, LLC |
13F
|
Company |
0.15%
|
42,206
|
$793,895 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.14%
|
38,361
|
$721,570 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.13%
|
36,925
|
$694,559 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
32,407
|
$609,576 | — | 30 Sep 2024 | |
| Lion Point Capital, LP |
13F
|
Company |
0.12%
|
32,000
|
$601,920 | — | 30 Sep 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.09%
|
25,353
|
$476,890 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
24,030
|
$452,005 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.09%
|
23,759
|
$446,907 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
20,520
|
$385,981 | — | 30 Sep 2024 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.06%
|
17,500
|
$329,175 | — | 30 Sep 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.06%
|
16,806
|
$316,121 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.06%
|
16,391
|
$308,314 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
16,146
|
$303,707 | — | 30 Sep 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.06%
|
15,816
|
$297,499 | — | 30 Sep 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.05%
|
14,743
|
$277,316 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
13,354
|
$251,189 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
13,109
|
$246,573 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
12,236
|
$230,159 | — | 30 Sep 2024 |
Institutional Holders of Jasper Therapeutics, Inc. - Voting Common Stock (JSPR) as of Q4 2024
As of 31 Dec 2024,
Jasper Therapeutics, Inc. - Voting Common Stock (JSPR) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,646,434 shares.
The largest 10 holders included
Soleus Capital Management, L.P., Velan Capital Investment Management LP, Carlyle Group Inc., Qiming U.S. Ventures Management, LLC, BlackRock, Inc., BRAIDWELL LP, VANGUARD GROUP INC, Integral Health Asset Management, LLC, MORGAN STANLEY, and Samsara BioCapital, LLC.
This page lists
85
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
77
Q4 2024 holders
84
Holder diff
7
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.